AL101-PSO

N/A

Report date: 2024/08/02 15:30:33

NME

Base Information

Drug NameAL101-PSO

Drug Alias NameAL101-PSO

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionAngiogenesis inhibitors

TargetsNot applicable

Therapy Area/IndicationsPsoriasis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesAngiolab Inc

China Registration ClassN/A

Active CompaniesAngiolab Inc

Inactive CompaniesN/A

Active IndicationsPsoriasis

Inactive IndicationsN/A

ATC CodeN/A